Abvc Biopharma ABVC
NASDAQ ABVC
$0.89 -0.01 (-1.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Long-Term Deferred Tax (2014 - 2025)

Abvc Biopharma's (ABVC) quarterly Long-Term Deferred Tax came in at $6.0 million in Q3 2025, down 0.87% on a QoQ basis from $6.0 million in Q2 2025.

Abvc Biopharma (ABVC) Long-Term Deferred Tax (2014 - 2025) Analysis & Trends

Abvc Biopharma (ABVC) has 10 years of Long-Term Deferred Tax data on file, last reported at $6.0 million in Q3 2025.

  • Quarterly Long-Term Deferred Tax changed N/A year-over-year to $6.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.0 million (changed N/A YoY) and the FY2024 annual result came in at $5.7 million, down 9.62% from the prior year.
  • Long-Term Deferred Tax eased to $6.0 million in Q3 2025, from $6.0 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $6.6 million in Q4 2022 to a low of $34256.0 in Q3 2023.
  • A 5-year average of $3.1 million and a median of $1.9 million in 2021 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2023 — Long-Term Deferred Tax slumped 96.72% — and 2024, when it surged 17498.35%.
  • Tracing ABVC's Long-Term Deferred Tax over 5 years: stood at $981912.0 in 2021, then jumped by 569.77% to $6.6 million in 2022, then retreated by 4.49% to $6.3 million in 2023, then decreased by 9.62% to $5.7 million in 2024, then rose by 5.61% to $6.0 million in 2025.
  • The last three Long-Term Deferred Tax figures came in at $6.0 million (Q3 2025), $6.0 million (Q2 2025), and $5.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Abvc Biopharma 23.19 Mn 23.19 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 6.00 Mn
Jun 30, 2025 6.05 Mn
Dec 31, 2024 5.68 Mn
Jun 30, 2024 6.24 Mn
Mar 31, 2024 6.25 Mn
Dec 31, 2023 6.28 Mn
Sep 30, 2023 34,256.00
Jun 30, 2023 35,472.00
Mar 31, 2023 118,191.00
Dec 31, 2022 6.58 Mn
Sep 30, 2022 1.01 Mn
Jun 30, 2022 1.08 Mn
Mar 31, 2022 1.04 Mn
Dec 31, 2021 981,912.00
Sep 30, 2021 1.99 Mn
Jun 30, 2021 1.91 Mn
Mar 31, 2021 1.82 Mn
Dec 31, 2020 1.79 Mn
Sep 30, 2020 1.65 Mn
Jun 30, 2020 1.58 Mn